Eli Lilly and Co, LLY:NYQ summary - FT.com - Financial Times
5 天之前 · Latest Eli Lilly and Co (LLY:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn
2025年1月11日 · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn, according to …
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
2024年10月30日 · Weight-loss drugmaker Eli Lilly delivered lower sales and earnings per share than expected in the third quarter, blaming high manufacturing costs and fluctuating inventory …
Eli Lilly & Co - Financial Times
2025年1月22日 · Can Eli Lilly become the first $1tn drugmaker? The latest news, analysis and opinion on Eli Lilly & Co. In-depth analysis, industry insights and expert opinion.
Lilly in advanced talks to buy cancer biotech Scorpion for up to …
2025年1月10日 · Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks told Financial Times’ Oliver …
Eli Lilly and Co, LLY:NYQ interactive chart - FT.com - Financial Times
Latest Eli Lilly and Co (LLY:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Eli Lilly in talks to acquire Scorpion Therapeutics, FT says; Relay ...
2025年1月10日 · Eli Lilly (NYSE: LLY) is expected to pay around $1 billion upfront for the privately owned Scorpion, according to a Financial Times report on Friday, which cited people familiar …
Lilly swoops on Morphic to claim IBD drug candidate
2024年7月8日 · Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057.
Harvest Eli Lilly High Income Shares ETF - Class A Units
Harvest Eli Lilly High Income Shares ETF - Class A Units + Add to watchlist + Add to portfolio Add to watchlist + Add to portfolio
Can Eli Lilly become the first $1tn drugmaker? - Financial Times
2024年10月2日 · Eli Lilly beat out its Danish competitor Novo Nordisk for the rights to the experimental drug after a short bidding war, paying just $50mn upfront, according to two …